Literature DB >> 22218874

The impact of vitamin D status and tumor size on the intraoperative parathyroid hormone dynamics in patients with symptomatic primary hyperparathyroidism.

Gaurav Agarwal1, Dhalapathy Sadacharan, Pooja Ramakant, Manoj Shukla, Saroj K Mishra.   

Abstract

PURPOSE: The intraoperative parathyroid hormone (IOPTH) monitoring is a useful adjunct for predicting whether a cure has been obtained during parathyroidectomy. We studied the influence of vitamin D status and parathyroid tumor weight on the IOPTH dynamics for predicting a cure in patients with symptomatic primary hyperparathyroidism.
METHODS: Fifty-nine primary hyperparathyroidism patients with a single adenoma underwent curative surgery. Patients were grouped according to their serum 25-hydroxy vitamin D levels (deficient, insufficient and sufficient) and tumor weights (small, large and giant). The IOPTH results in patient groups were compared, and the percentage of the IOPTH decrease was examined for a correlation with the serum 25-hydroxy vitamin D level and tumor weight.
RESULTS: The sensitivity, specificity and overall accuracy of IOPTH in predicting a cure of hyperparathyroidism were 94.8, 100 and 93.2%, respectively. The percentage decrease in the IOTPH was significantly higher in the vitamin D deficient, compared to the vitamin D sufficient patients (p = 0.012); and in the patients with larger tumors, compared to those with smaller parathyroid tumors (p = 0.02). A statistically significant correlation was found between the percentage decrease in the IOPTH at 10 min post-tumor excision and the serum 25-hydroxy vitamin D level (p = 0.037), but not with the tumor weight (p = 0.208).
CONCLUSIONS: The IOPTH can accurately predict a cure in patients with severe primary hyperparathyroidism. The percentage of decrease in the IOPTH is steeper in patients with lower serum 25-hydroxy vitamin D levels and larger parathyroid tumors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22218874     DOI: 10.1007/s00595-011-0113-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  20 in total

1.  Predictors of intra-operative parathyroid hormone decline in subjects operated for primary hyperparathyroidism by minimally invasive parathyroidectomy.

Authors:  M-H Gannagé-Yared; B Abboud; M Amm-Azar; A Saab; S Khalife; G Halaby; C Atallah; R Medlej; S Jambart
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

2.  Persistently elevated parathyroid hormone levels after parathyroid surgery.

Authors:  Tracy S Wang; Samuel T Ostrower; Keith S Heller
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

3.  Indian primary hyperparathyroidism patients with parathyroid carcinoma do not differ in clinicoinvestigative characteristics from those with benign parathyroid pathology.

Authors:  Gaurav Agarwal; Kaushal K Prasad; Dilip K Kar; Narendra Krishnani; Rakesh Pandey; Saroj K Mishra
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

4.  A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable?

Authors:  Herbert Chen; Eberhard Mack; James R Starling
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

5.  Intraoperative calcium monitoring is insufficient to predict the surgical success of parathyroidectomy for primary hyperparathyroidism.

Authors:  Peter Gassmann; Norbert Senninger; Mario Colombo-Benkmann
Journal:  Surg Today       Date:  2010-11-26       Impact factor: 2.549

6.  Long-term outcome after parathyroidectomy in patients with advanced primary hyperparathyroidism and associated vitamin D deficiency.

Authors:  P V Pradeep; Anjali Mishra; Gaurav Agarwal; Amit Agarwal; A K Verma; S K Mishra
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

7.  Elevated serum parathormone level after "concise parathyroidectomy" for primary sporadic hyperparathyroidism.

Authors:  Sally E Carty; Michelle M Roberts; Mohamed A Virji; Laura Haywood; John H Yim
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

8.  Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.

Authors:  Brian R Untch; Michael E Barfield; Moahad Dar; Darshana Dixit; George S Leight; John A Olson
Journal:  Surgery       Date:  2007-12       Impact factor: 3.982

9.  Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism.

Authors:  Neşe Ozbey; Yeşim Erbil; Evin Ademoğlu; Selçuk Ozarmağan; Umut Barbaros; Alp Bozbora
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

Review 10.  Peer-reviewed, evidence-based analysis of vitamin D and primary hyperparathyroidism.

Authors:  Storm Weaver; David B Doherty; Camilo Jimenez; Nancy D Perrier
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

View more
  3 in total

Review 1.  Primary hyperparathyroidism-related giant parathyroid adenoma (Review).

Authors:  Adina Ghemigian; Alexandra Ioana Trandafir; Eugenia Petrova; Mara Carsote; Ana Valea; Alexandru Filipescu; Ana-Maria Oproiu; Florica Sandru
Journal:  Exp Ther Med       Date:  2021-11-26       Impact factor: 2.447

2.  THE VOLUME OF SOLITARY PARATHYROID ADENOMA IS RELATED TO PREOPERATIVE PTH AND 25OH-D3, BUT NOT TO CALCIUM LEVELS.

Authors:  A Gatu; C Velicescu; A Grigorovici; R Danila; V Muntean; S J Mogoş; V Mogoş; C Vulpoi; C Preda; D Branisteanu
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Oct-Dec       Impact factor: 0.877

3.  Comparison between Second- and Third-Generation PTH Assays during Minimally Invasive Parathyroidectomy (MIP).

Authors:  Marie-Hélène Gannagé-Yared; Nada Younès; Anne-Sophie Azzi; Ghassan Sleilaty
Journal:  Int J Endocrinol       Date:  2020-03-16       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.